| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 621360 | Null | 0.00888636978630782 | 0.60261865 |
| NSC 633498 | Null | 0.00888636978630782 | 0.54186238 |
| NSC 668814 | 1-Oxa-4,7,10,13,16-pentaazacyclononadecane, cyclic peptide derivative | 0.00888636978630782 | -0.34121303 |
| NSC 701018 | Null | 0.00888636978630782 | -0.0044309653 |
| NSC 736914 | Null | 0.00888636978630782 | 0.39682291 |
| NSC 677666 | Null | 0.00940302282078401 | 0.19487864 |
| NSC 696660 | (6R,6S)-2,4-Diamino-6-(3,4-dimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline | 0.00940302282078401 | 0.061549388 |
| NSC 698980 | Null | 0.00940302282078401 | 0.099706285 |
| NSC 744622 | 4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide | 0.00940302282078401 | 0.10892423 |
| NSC 135929 | Null | 0.0115521552688257 | 0.48502761 |